Mercer Global Advisors Inc Supernus Pharmaceuticals, Inc. Transaction History
Mercer Global Advisors Inc
- $45.6 Billion
- Q3 2024
A detailed history of Mercer Global Advisors Inc transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 11,100 shares of SUPN stock, worth $393,273. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,100
Previous 11,393
2.57%
Holding current value
$393,273
Previous $304,000
13.82%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding SUPN
# of Institutions
281Shares Held
60.6MCall Options Held
27.7KPut Options Held
11.3K-
Black Rock Inc. New York, NY10.4MShares$368 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.13MShares$217 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.1MShares$181 Million2.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$102 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$93.2 Million0.09% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.9B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...